PMHS — Polomar Health Services Share Price
Last trade - 00:00- $5.53m
- $6.71m
- $0.06m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.68 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 87.29 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -20.2% | ||
| Return on Equity | -42.91% | ||
| Operating Margin | -2597.25% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | 0.03 | n/a | 0.06 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Polomar Health Services, Inc. operates Polomar Specialty Pharmacy, LLC (Polomar Specialty Pharmacy), a State of Florida licensed retail compounding pharmacy. Polomar Specialty Pharmacy is also licensed as a Special Sterile Compounding Pharmacy, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The Company also owns SlimRx (www.slimrx.com), a weight-loss focused online platform that connects patients with licensed physicians to prescribe weight-loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin (VitaSlim and VitaSlim Plus). The Company also focuses on launching PoloMeds (polomeds.com) to fulfill prescriptions for diabetes medications, including metformin compounds, sulfonylureas, and insulin; compounded erectile dysfunction medications inhalable sildenafil and Polomar’s prescription only, exclusive dermatological formulations.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- September 14th, 2000
- Public Since
- November 10th, 2008
- No. of Shareholders
- 175
- No. of Employees
- 2
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 27,657,679
- Address
- 10940 Wilshire Boulevard, Suite 1500, LOS ANGELES, 90024
- Web
- https://www.trustfeed.com/
- Phone
- +1 2122453413
- Auditors
- GreenGrowth CPAs
Upcoming Events for PMHS
Similar to PMHS
American Green
Pink Sheets on Nasdaq
Bespoke Extracts
Pink Sheets on Nasdaq
Bit Brother
Pink Sheets on Nasdaq
Blue Gem Enterprise
Pink Sheets on Nasdaq
Blum Holdings
Pink Sheets on Nasdaq
FAQ
As of Today at 22:41 UTC, shares in Polomar Health Services are trading at $0.20. This share price information is delayed by 15 minutes.
Shares in Polomar Health Services last closed at $0.20 and the price had moved by -85.71% over the past 365 days. In terms of relative price strength the Polomar Health Services share price has underperformed the S&P500 Index by -87.69% over the past year.
There is no consensus recommendation for this security.
Find out morePolomar Health Services does not currently pay a dividend.
Polomar Health Services does not currently pay a dividend.
Polomar Health Services does not currently pay a dividend.
To buy shares in Polomar Health Services you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.20, shares in Polomar Health Services had a market capitalisation of $5.53m.
Here are the trading details for Polomar Health Services:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: PMHS
Based on an overall assessment of its quality, value and momentum Polomar Health Services is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Polomar Health Services. Over the past six months, its share price has underperformed the S&P500 Index by -53.51%.
As of the last closing price of $0.20, shares in Polomar Health Services were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Polomar Health Services PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Polomar Health Services' management team is headed by:
- Rasmus Refer - CEO